Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China.

An, Zhijie; Wang, Fuzhen; Pan, An; Yin, Zundong; Rodewald, Lance; Feng, Zijian

An, Zhijie; Wang, Fuzhen; Pan, An; Yin, Zundong; Rodewald, Lance; Feng, Zijian.

An Z; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Wang F; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Pan A; School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yin Z; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Rodewald L; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Feng Z; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China fengzj@chinacdc.cn.

BMJ ; 375: e066125, 2021 12 01.

Article in English | MEDLINE | ID: covidwho-1546490

Subject(s)

COVID-19 Vaccines/immunology; COVID-19/immunology; COVID-19/prevention & control; Mass Vaccination/organization & administration; COVID-19/epidemiology; China/epidemiology; Humans; Mass Vaccination/statistics & numerical data; Pandemics; Quarantine; Risk Assessment; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mass Vaccination / COVID-19 Vaccines / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: BMJ Journal subject: Medicine Year: 2021 Document Type: Article Affiliation country: Bmj-2021-066125

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google